Amplicons for intI1 and VR were obtained from 22/24 isolates. We detected three different VR arrays spanning 1,000, 3,500, and 4,000 bp and harboring the following genes: 5= conserved sequence (5=CS)-bla VIM-2 -3=CS, 5=CS-bla VIM-2 -aacA4-cmlA6-catB11-3=CS (INTEGRALL database name In1270), and 5=CS-bla VIM-2 -bla GES-7 -aacA7-aacA4-aacA7-3=CS (INTEGRALL database name In1271).
Although the 1,000-bp VR is identical to In899 (13) , this is the first description of In1270 and In1271; both include amikacin and/or tobramycin resistance genes (aacA4 and/or aacA7); furthermore, in In1271 (detected in P. putida) the occurrence of bla GES-7 also adds resistance to aztreonam.
The coexistence of bla VIM and bla GES derivatives in P. aeruginosa isolates has already been described (14) ; however, to the best of our knowledge, this is the first description of an integron featuring both genes. Additionally, bla GES-7 in P. aeruginosa ST111 was described previously in 2014 by Guzvinec et al. (15) .
In899 was detected in P. aeruginosa and P. putida obtained from M1, M2 (P. aeruginosa isolates from both hospitals), and F1 (P. putida isolates). In contrast, In1270 was present in P. aeruginosa isolates obtained from F1 and in P. putida isolates from M1 and M2. This strongly suggests horizontal-transmission events of these genetic elements among different Pseudomonas species isolated in distinct Uruguayan hospitals, as previously indicated (9, 16) .
The detection of new VRs and the occurrence of ST155, previously described as a successful clone (17) , constitutes an alert for health care systems. Accession number(s). The sequences of integrons In1270 and In1271 were deposited into the EMBL database under accession numbers LT222321 and LT222320, respectively.
